CCK4 (PTK7) Antibody (N-term) Blocking peptide
€363.00
In stock
SKU
AC-BP7716a
Background:
PTK7 may function as a cell adhesion molecule. Although it belongs to the insulin receptor subfamily of Tyr protein kinases, it likely lacks the catalytic activity of a tyrosine kinase. It may be connected to the pathophysiology of colon carcinomas and/or may represent a tumor progression marker. This Type I membrane protein is highly expressed in lung, liver, pancreas, kidney, placenta and melanocytes, and it is weakly expressed in thyroid gland, ovary, brain, heart and skeletal muscle, and not in colon. Expression is also detected in erythroleukemia cells.
Other Names:
Inactive tyrosine-protein kinase 7, Colon carcinoma kinase 4, CCK-4, Protein-tyrosine kinase 7, Pseudo tyrosine kinase receptor 7, Tyrosine-protein kinase-like 7, PTK7, CCK4
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7716a was selected from the N-term region of human PTK7 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: PTK7
Gene ID: 5754
Primary Accession: Q13308
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
PTK7 may function as a cell adhesion molecule. Although it belongs to the insulin receptor subfamily of Tyr protein kinases, it likely lacks the catalytic activity of a tyrosine kinase. It may be connected to the pathophysiology of colon carcinomas and/or may represent a tumor progression marker. This Type I membrane protein is highly expressed in lung, liver, pancreas, kidney, placenta and melanocytes, and it is weakly expressed in thyroid gland, ovary, brain, heart and skeletal muscle, and not in colon. Expression is also detected in erythroleukemia cells.
Other Names:
Inactive tyrosine-protein kinase 7, Colon carcinoma kinase 4, CCK-4, Protein-tyrosine kinase 7, Pseudo tyrosine kinase receptor 7, Tyrosine-protein kinase-like 7, PTK7, CCK4
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7716a was selected from the N-term region of human PTK7 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: PTK7
Gene ID: 5754
Primary Accession: Q13308
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review